Caxton Associates LLP Invests $429,000 in Option Care Health, Inc. $OPCH

Key Points

• Caxton Associates LLP invested approximately $429,000 in Option Care Health by purchasing 12,268 shares during the 1st quarter, reflecting growing interest from institutional investors.
• Analysts have set a consensus rating of Moderate Buy for Option Care Health, with a target price of $35.75, supported by strong quarterly earnings that exceeded expectations.
• Insider activity shows significant purchasing, with directors acquiring over 23,000 shares in recent transactions, indicating confidence in the company's future performance.

Caxton Associates LLP purchased a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 12,268 shares of the company's stock, valued at approximately $429,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. grew its stake in shares of Option Care Health by 1,492.9% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after buying an additional 836 shares during the last quarter. Brooklyn Investment Group grew its stake in shares of Option Care Health by 186.6% in the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock worth $42,000 after buying an additional 780 shares during the last quarter. Public Employees Retirement System of Ohio grew its stake in shares of Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after buying an additional 332 shares during the last quarter. Bessemer Group Inc. grew its stake in shares of Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after buying an additional 599 shares during the last quarter. Finally, Wealthquest Corp purchased a new stake in shares of Option Care Health in the 1st quarter worth approximately $66,000. Hedge funds and other institutional investors own 98.05% of the company's stock.

Analysts Set New Price Targets

Several research firms recently weighed in on OPCH. Barrington Research restated an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research note on Thursday, July 10th. Citigroup restated an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Finally, JMP Securities increased their target price on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research note on Thursday, July 31st. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Stock Performance

Shares of OPCH opened at $28.48 on Friday. The business's fifty day simple moving average is $29.09 and its two-hundred day simple moving average is $31.44. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The company has a market cap of $4.62 billion, a price-to-earnings ratio of 22.78, a P/E/G ratio of 1.79 and a beta of 0.82.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.01. The firm had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The company's revenue was up 15.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Research analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Norman L. Wright purchased 3,411 shares of the stock in a transaction dated Tuesday, September 9th. The shares were purchased at an average cost of $29.31 per share, with a total value of $99,976.41. Following the acquisition, the director directly owned 15,501 shares of the company's stock, valued at $454,334.31. This represents a 28.21% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy P. Sullivan purchased 20,000 shares of the stock in a transaction dated Thursday, August 21st. The shares were purchased at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the acquisition, the director directly owned 49,229 shares in the company, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought 59,411 shares of company stock valued at $1,627,576 in the last ninety days. 0.64% of the stock is currently owned by company insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.